How should the Dengue Duo rapid test be used and interpreted in a patient with suspected dengue infection?

Dengue Duo Rapid Test: Use and Interpretation

The Dengue Duo rapid test (detecting NS1 antigen, IgM, and IgG) should be used as a point-of-care diagnostic tool in suspected dengue cases, with interpretation based on timing of symptom onset: NS1 positivity indicates acute infection in early disease (≤7 days), while combined NS1/IgM/IgG results significantly improve diagnostic sensitivity to 83.7% when any component is positive. 1, 2

Test Components and Clinical Performance

The Dengue Duo rapid test detects three markers simultaneously:

• NS1 antigen: Indicates active viral replication and acute infection 3, 4
• IgM antibodies: Appear later in acute phase, persist for months 5
• IgG antibodies: Indicate past infection or secondary dengue 1, 2

Overall diagnostic performance when combining all three markers reaches 83.7% sensitivity and 89.66% specificity, significantly better than NS1 alone (61.6-62.4% sensitivity) 1, 2, 6

Timing-Based Interpretation Algorithm

Specimens Collected ≤7 Days After Symptom Onset

For early acute phase samples, NS1 antigen is the primary diagnostic marker:

• NS1 positive = Acute dengue infection highly likely (specificity 100%) 2, 3
• NS1 negative but IgM/IgG positive = Perform confirmatory testing with NAAT or repeat serology, as negative acute IgM may reflect collection before antibody development 5
• All markers negative = Does not rule out dengue; NAAT should be performed if available 5

Critical caveat: NS1 sensitivity correlates strongly with viral load and decreases rapidly over the acute phase, dropping significantly after day 3-5 of illness 3, 4

Specimens Collected >7 Days After Symptom Onset

For later acute and convalescent phase samples, antibody detection becomes more reliable:

• IgM positive (with or without IgG) = Recent dengue infection likely; perform confirmatory PRNT if definitive diagnosis needed 5
• IgG positive alone = Past infection; does not confirm current acute infection 1, 2
• Both IgM and IgG negative = Rules out recent dengue infection when collected 7 days to 12 weeks after onset 5

Primary vs. Secondary Infection Patterns

NS1 sensitivity is significantly higher in primary infections (87-93%) compared to secondary infections, where pre-existing IgG antibodies reduce NS1 detection:

• Primary infection: NS1 positive early, IgM appears days 4-7, IgG appears later 3, 2
• Secondary infection: NS1 may be negative or weakly positive due to rapid antibody-mediated viral clearance; IgG rises rapidly and early 3, 4

The presence of high IgG titers at presentation suggests secondary infection and may compromise NS1 sensitivity 3, 2

Confirmatory Testing Requirements

When rapid test results are positive but definitive diagnosis is needed for clinical or epidemiologic purposes, confirmatory testing is mandatory:

• Positive NS1 or IgM without NAAT confirmation = Perform PRNT against dengue, Zika, and other endemic flaviviruses 5
• PRNT titer ≥10 for dengue with <10 for Zika/other flaviviruses = Confirms recent dengue infection 5, 7
• PRNT titer ≥10 for both dengue and Zika = Recent flavivirus infection confirmed but specific virus cannot be identified 5, 7

Indeterminate (Trace) Results

Trace-positive IgM results are classified as indeterminate and require additional testing:

• Repeat IgM testing on the same specimen OR perform confirmatory PRNT as first-line approach 7
• If unavailable, obtain second serum specimen for repeat IgM testing 7
• Indeterminate results may represent early antibody response before full seroconversion or cross-reactivity with other flaviviruses 7

Cross-Reactivity and Endemic Area Considerations

In dengue-endemic regions where secondary flavivirus infections are common, diagnostic sensitivity of both NS1 and IgM components may be compromised:

• Cross-reactivity occurs with Zika, yellow fever, Japanese encephalitis, and other flaviviruses 3, 7
• IgM antibodies persist for months after infection; positive IgM alone cannot determine timing of infection 5, 7
• Interpretation must incorporate local epidemiology of circulating dengue serotypes and co-circulating flaviviruses 5, 7

Special Population: Pregnant Women

Pregnant women with suspected dengue require concurrent testing:

• Perform both NAAT and IgM antibody testing on serum plus NAAT on urine for Zika virus 5
• Specimens should be collected ≤12 weeks of symptom onset for optimal Zika NAAT sensitivity 5
• Same interpretation algorithm applies, but prolonged IgM persistence limits timing determination 7

Clinical Management Implications

A positive Dengue Duo result highly suggests dengue, but a negative result does not rule out infection:

• Positive result = Manage as confirmed dengue with appropriate supportive care and monitoring for warning signs 1
• Negative result in early phase (<7 days) = Consider NAAT testing; do not exclude dengue based on negative rapid test alone 1, 5
• Negative result in late phase (>7 days) = Dengue unlikely if both IgM and IgG negative; consider alternative diagnoses 5

Quality Assurance Requirements

Optimal performance requires adequate training and quality assurance:

• Field sensitivity (85.7%) is lower than reference laboratory sensitivity (94.4%) when training is inadequate 1
• Proper technique and interpretation training are essential to achieve manufacturer-specified performance 1
• Higher sensitivity observed in acute phase (93.03%) versus convalescent phase (81.82%) 6